Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04991974 · ClinicalTrials.gov registry record · Phase 2
Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine
A Phase 2 study, sponsored by Friends Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 373
- Enrollment target
NCT04991974 is a Phase 2 study that has completed, run by Friends Research Institute. The registered enrollment target is 373 participants.
The verdict
NCT04991974, a Phase 2 study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 373 participants
- Enrollment target
Study Summary
This study will examine the effectiveness of opioid use disorder (OUD) treatment linkage strategies for patients identified at sexual health clinics and through community outreach and referrals. This 3-arm RCT will compare Usual Care vs. Patient Navigation vs. Patient Navigation + Buprenorphine Initiation (UC vs. PN vs. PN+BUP).
Interventions
- DRUG Buprenorphine
- BEHAVIORAL Patient Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 373 participants |
| Start Date | 2021-09-17 |
| Est. Completion | 2026-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04991974
The ClinicalTrials.gov registry entry for NCT04991974 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 373 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buprenorphine is the first listed.
NCT04991974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04991974 about?
NCT04991974 is a clinical study titled "Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine". This study will examine the effectiveness of opioid use disorder (OUD) treatment linkage strategies for patients identified at sexual health clinics and through community outreach and referrals. This 3-arm RCT will compare Usual Care vs. Patient Navigation vs. Patient Navigation + Buprenorphine Init...
What is the current status of trial NCT04991974?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 373 participants. The study started on 2021-09-17. Estimated completion is 2026-01-31.
What interventions are being tested in trial NCT04991974?
The interventions under investigation include: Buprenorphine (DRUG), Patient Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04991974?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.